Anka Veleva

Clave Biodesign, Inc.

$1,506,000

Attributed

$1,506,000

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY2013–20

$2M$1.5M$1M$500K$0

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NSF$1,506,000 · 4

By mechanism

—$1,506,000 · 4

Top collaborators

No co-investigators on record.

Grant awards (4)

SBIR Phase II: Lignin-Based Formulations for Efficient and Sustainable Control of Plant Pathogens$800,000

· FY2020 · TIP · contact PI

SBIR Phase I: COVID-19-impermeable high-performance porous coatings for respiratory personal protective equipment$256,000

· FY2020 · TIP · contact PI

SBIR Phase I: Lignin-Based Formulations for Efficient and Sustainable Control of Plant Pathogens$225,000

· FY2018 · TIP · contact PI

STTR Phase I: Novel Molecularly Targeted Tracer for Specific and Sensitive Imaging of Cancer$225,000

· FY2013 · TIP · contact PI